Effectiveness research and implications for study design: Sample size and statistical power

General Hospital Psychiatry

Volumn 21, Issue 4, 1999, Pages 274-283

  Sturm, Roland ^a   Unützer, Jürgen ^b   Katon, Wayne ^c  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; HYPOTHESIS; MEDICAL LITERATURE; MEDICAL RESEARCH; METHODOLOGY; OUTCOMES RESEARCH; QUALITY OF LIFE; SAMPLE;

CLINICAL TRIALS; RESEARCH DESIGN; STATISTICS;

EID: 0344199951     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-8343(99)00024-9     Document Type: Article

References (31)

1. National Advisory Mental Health Council: Bridging Science and Service: A Report by the National Advisory Mental Health Council's Clinical Treatment and Services Research Workgroup. National Institutes of Health, National Institute of Mental Health, Bethesda, MD, 1998
2. Simon G, Wagner E, VonKorff M: Cost-effectiveness comparisons using "real world" randomized trials: the case of new antidepressant drugs. J Clin Epidemiol 48:363-373, 1995
3. Wells KB, Sturm R, Sherbourne CD, Meredith LS: Caring for Depression. Cambridge, MA, Harvard University Press, 1996
4. nd ed. Philadelphia, PA, Lippincott-Rave, 155-159, 1996
5. Wells KB: Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 156:5-10, 1999
6. Newcombe RG: Towards a reduction in publication bias. Br Med J (Clin Res Ed) 295:656-659, 1987
7. Rossi JS: Statistical power of psychological research: what have we gained in 20 years? J Consult Clin Psychol 58:646-656, 1990
8. Fox N, Mathers N: Empowering research: statistical power in general practice research. Fam Pract 14:324-329, 1997
9. Sturm R, Wells KB: How can care for depression become more cost effective? JAMA 273:51-58, 1995
10. Sturm R: How expensive is unlimited mental health care coverage under managed care. JAMA 278:1533-1537, 1997
11. Sturm R: How does risk sharing between employers and managed behavioral health organizations affect mental health care? UCLA/RAND Center on Managed Care, Los Angeles; Working Paper No. 113, 1997
12. Katon W, Von Korff M, Lin E, et al: Collaborative management to achive treatment guidelines: impact on depression in primary care. JAMA 273:1026-1031, 1995
13. Von Korff M, Katon W, Bush T, et al: Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med 60:143-149, 1998
14. Simon GE, Katon W, Ruter C, et al: Impact of improved depression treatment in primary care on daily functioning and disability. Psychol Med 28:693-701, 1998
15. Unützer J, Patrick DL, Simon G, et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. JAMA 277:1618-1623, 1997
16. Newhouse JP: Insurance Experiment Group. Free for All? Lessons from the RAND Health Insurance Experiment. Cambridge, MA: Harvard University Press, 1993
17. Ware JE, Sherbourne CD: The MOS 36-Item Short-Form Health Survey (SF-36). Med Care 30:473-481, 1992
18. Stewart AL, Ware JE (eds): Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC, Duke University Press, 1992
19. Oss ME, Drissel AB, Clary J: Managed Behavioral Health Market Share in the United States, 1997-1998. Gettysburg, PA, Behavioral Health Industry News, 1997
20. Sturm R, Zhang W, Schoenbaum M: How expensive are unlimited substance abuse benefits under managed care? J Behav Health Ser Res 26:203-210, 1999
21. Sturm R, Goldman W, McCulloch J: Mental health and substance abuse parity: a case study of Ohio's state employee program. J Men Health Policy Econ 1:129-134, 1998
22. Ma CA, McGuire TG: Costs and incentives in a mental health carve-out. Health Aff (Millwood) 17:53-69, 1998
23. Sturm R, McCulloch J: Mental health and substance abuse benefits in carve-out plans and the Mental Health Parity Act of 1996. J Health Care Finance 24:84-95, 1998
24. Wells KB, Sturm R: Care for depression in a changing environment. Health Aff (Millwood) 14:78-89, 1995
25. Gold MR, Siegel JE, Russell LB, et al. (eds): Cost Effectiveness in Health and Medicine. New York, Oxford University Press, 1996
26. Duan N, Manning WG, Morris CN, et al: A comparison of alternative models for the demand for medical care. J Business Econ Stat 1:115-126, 1983
27. Manning WG: The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 17:283-296, 1998
28. Julious SA, George S, Campbell MJ: Sample sizes for studies using the short form 36 (SF-36). J Epidemiol Community Health 49:642-644, 1995
29. Simon GE, VonKorff M, Heiligenstein JH, et al: Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 275:1897-1902, 1996
30. Mills JL: Data torturing. N Engl J Med 329:1196-1199, 1993
31. Wells KB: The design of partners in care: evaluating the cost-effectiveness of improving care for depression. Soc Psychiatry Psychiatr Epidemiol 34:20-29, 1999